NCT01756300View on ClinicalTrials.gov

RENABLATE Feasibility Study CS156 (EC12-02) Study of Catheter Based Renal Denervation to Treat Resistant Hypertension

PHASE1CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

November 30, 2013

Study Completion Date

April 30, 2015

Conditions
Hypertension, Renal
Interventions
DEVICE

Celsius® ThermoCool® RD

The investigational device is designed to transmit radiofrequency (RF) current to the electrodes for ablation purposes, specifically for the treatment of resistant hypertension by renal denervation.

All Listed Sponsors
lead

Biosense Webster, Inc.

INDUSTRY

NCT01756300 - RENABLATE Feasibility Study CS156 (EC12-02) Study of Catheter Based Renal Denervation to Treat Resistant Hypertension | Biotech Hunter | Biotech Hunter